Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

7th Oncolytic Virotherapy Summit 2022

Evvnt Promotion / evvnt
-
06.12.2022 - 08.12.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am to 4:00 pm
 
Temi della conferenza
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immunotherapy. With rapid advances in this compelling therapeutic, the Oncolytic Virotherapy Summit returns this December 2022 for its 7th edition.
Scientific organizer
Hanson Wade
Annotazioni
Speakers: Antonio Chiocca, Chairman, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Barbara Haertl, Associate Vice President, Manufacturing Operations, Calidi Biotherapeutics
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1259262-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Sanità Pubblica (Public Health), Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 4897.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceÄrzte der WeltHelix - Forschung & Beratung WienAlumni Club Medizinische Universität WienCharité International AcademyAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaÖsterreichische Gesellschaft für Public Health